Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Regulatory
  • Pazdur declines to announce candidacy for vacated FDA commissioner role
  • Regulatory

Pazdur declines to announce candidacy for vacated FDA commissioner role

BioSpace

FDA veteran Richard Pazdur outlined his priorities for the next FDA commissioner but stopped short of putting himself forward as a candidate to lead the agency at an RBC Capital Markets event on Tuesd

Read full story

pharminent May 20, 2026 (Last updated: May 20, 2026)

BioSpace

FDA veteran Richard Pazdur outlined his priorities for the next FDA commissioner but stopped short of putting himself forward as a candidate to lead the agency at an RBC Capital Markets event on Tuesd

Read full story

Post navigation

Previous: Pepaxti study supports use in wider myeloma population
Next: Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update

Related Stories

  • Regulatory

Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion

pharminent September 10, 2026
  • Regulatory

HHS appoints permanent FDA CBER, CDER heads

pharminent September 10, 2026
  • Regulatory

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer

pharminent September 7, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.